ArticleJournal of the American Heart Association2025

Health Care Resource Use and Costs of Rivaroxaban Versus Warfarin Among Nonvalvular Atrial Fibrillation Polypharmacy Patients With Obesity.

Mark Alberts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.